Inhibition of Human Natural Killer Cell Activity by Platelet‐Derived Growth Factor (PDGF)

Geoffrey M. Gersuk(Children's Hospital of Los Angeles), P K Pattengale(Children's Hospital of Los Angeles), A J Mohabeer(Children's Hospital of Los Angeles), Srisawai Pattamakom(Children's Hospital of Los Angeles), Bengt Westermark(Science for Life Laboratory), P. M. Challita(Children's Hospital of Los Angeles)
Scandinavian Journal of Immunology
May 1, 1991
10.1111/j.1365-3083.1991.tb02522.x
Cited by 51

Related Papers

Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
|Physiological Reviews|1999|2.5k
Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
|Nature|1983|1.6k
Growth factors: Mechanism of action and relation to oncogenes
|Cell|1984|880
cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines
|Nature|1986|790
A role for platelet-derived growth factor in normal gliogenesis in the central nervous system
|Cell|1988|769